dpp-4 inhibitors and glp-1 agonists dpp-4_inhibitors [TUSOM Specific actions of GLP-1 receptor
Description
3Assistant Professor, Department of Pathology, Dow University of Health Sciences, Karachi, Pakistan
Cell Mol Gastroenterology Hepatology
The rising use of GLP-1 RAs is accompanied by growing interest in their potential non-metabolic effects, including a possible impact on cancer risk
Retrieved 18 December 2023
13 GLP1-RAs have shown potential to reduce glycaemic variability while posing a low risk of hypoglycaemia
